Adapalene NDC 68308-666

NDC codes

FDA NDC Directory

Product NDC (as listed)68308-666Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68308-0666Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68308-666-25	68308066625	1 TUBE in 1 CARTON (68308-666-25) / 45 g in 1 TUBEMarketed from Feb 26, 2024
68308-666-45	68308066645	1 BOTTLE, PUMP in 1 CARTON (68308-666-45) / 45 g in 1 BOTTLE, PUMPMarketed from Feb 26, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adapalene
Generic name (nonproprietary): adapalene
Active ingredients: Adapalene — 3 mg/g
Dosage form: Gel
Route: Topical
Labeler: Mayne Pharma Commercial LLC.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 021753
Marketing start: Feb 26, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 68308-666_86366747-19bc-4279-8e62-afc7c8682e4bSPL ID 86366747-19bc-4279-8e62-afc7c8682e4bSPL set ID 9a0d9a0d-a9f3-4eb9-be76-166ef182d13aRxCUI 722111UNII 1L4806J2QF
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468308066625 followed by a unit qualifier and the quantity

Package 68308-0666-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 28, 2022.

Indications (excerpt from the label)

Adapalene Gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Adapalene Gel, 0.3%, is a retinoid, indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021753

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021753
Product	Strength	Form · route	Labeler	Product NDC
Differinadapalene	Adapalene 3 mg/g	GelTopical	Galderma Laboratories, L.P.	0299-5918